Sustained complete remission after chemobiohormonal therapy for metastatic melanoma

被引：3
|
作者：
Stein, ME
Bernstein, Z
Drumea, K
Zalik, M
Shklar, Z
Steiner, M
Haim, N
机构：
[1] Rambam Med Ctr, No Israel Oncol Ctr, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Fac Med, Haifa, Israel
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1999年 / 22卷 / 01期
关键词：
chemobiohormonal treatment; complete remission; metastatic melanoma;
D O I：
10.1097/00000421-199902000-00015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The combination of carmustine, cisplatin, dacarbazine interferon, and low-dose tamoxifen is widely used in treating metastatic melanoma and was originally reported to acheive a 20% complete response rate. Among 29 patients who completed the authors' phase TI study with the regimen, five (17%) achieved complete remission, and the median duration of response was 8 months (range, 2-14 months). The aim of the study was to evaluate briefly the value and toxicity of this regimen in treating metastatic malignant melanoma.
引用
收藏
页码：62 / 64
页数：3
相关论文
共 50 条
  • [21] Complete remission of a metastatic pancreatic carcinoma after modified G-FLIP therapy
    Alldinger, Ingo
    Tsamaloukas, Antonis G.
    Germing, Ulrich
    Hosch, Stefan B.
    Knoefel, Wolfram T.
    CHEMOTHERAPY, 2007, 53 (05) : 356 - 359
  • [22] Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study
    Stege, Henner
    Haist, Maximilian
    Schultheis, Michael
    Fleischer, Maria Isabel
    Mohr, Peter
    Meier, Friedegund
    Schadendorf, Dirk
    Ugurel, Selma
    Livingstone, Elisabeth
    Zimmer, Lisa
    Herbst, Rudolf
    Pfoehler, Claudia
    Kaehler, Katharina
    Weichenthal, Michael
    Terheyden, Patrick
    Nashan, Dorothee
    Debus, Dirk
    Kaatz, Martin
    Ziller, Fabian
    Haferkamp, Sebastian
    Forschner, Andrea
    Leiter, Ulrike
    Kreuter, Alexander
    Ulrich, Jens
    Kleemann, Johannes
    Bradfisch, Fabienne
    Grabbe, Stephan
    Loquai, Carmen
    CANCERS, 2021, 13 (10)
  • [23] Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy
    Azmi, Ahmad Najib
    Chan, Wah-Kheong
    Goh, Khean-Lee
    JOURNAL OF DIGESTIVE DISEASES, 2015, 16 (09) : 537 - 540
  • [24] DURATION OF REMISSION FOLLOWING COMPLETE RESPONSE (CR) TO CHEMOTHERAPY FOR METASTATIC MELANOMA
    HILL, GJ
    KREMENTZ, ET
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 188 - 188
  • [25] Long-lasting complete Remission of metastatic malignant melanoma after reinduction with Ipilimumab, a case Report
    Mueller-Brenne, Tina
    Stanger, Christian
    Grabbe, Stephan
    Loquai, Carmen
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2012, 10 (09): : 683 - 683
  • [26] Rapid and long-lasting complete remission of a metastatic melanoma with pembrolizumab
    Messinger, L.
    Hauschild, A.
    Kahler, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 160 - 160
  • [27] Sustained complete remission of metastatic oesophageal adenocarcinoma using long-term therapy with 5-fluorouracil
    Saletti, P
    Ghielmini, M
    Martinoli, S
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 2004, 15 (07) : 1145 - 1146
  • [28] Length of treatment after partial or complete remission in immunotherapy for metastatic melanoma: An EUMelaReg real world study
    Asher, Nethanel
    Mohr, Peter
    Ellebaek, Eva
    Bender, Marc
    Mangana, Joanna
    Kandolf, Lidija
    Gavrilova, Iva
    Ascierto, Paolo Antonio
    Gogas, Helen
    Rutkowski, Piotr
    Schadendorf, Dirk
    Bastholt, Lars
    Weichenthal, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Retreatment of Patients With Metastatic Cutaneous Melanoma Who Relapse After Elective Checkpoint Inhibitor Discontinuation After a Complete Remission
    Sadrolashrafi, Kaviyon
    Samlowski, Wolfram
    ONCOLOGIST, 2023, 28 (05): : E270 - E275
  • [30] Chemosensitivity of malignant melanoma models: Longterm complete remission after regional hyaluronidase/vinblastine therapy
    Spruss, T
    Bernhardt, G
    IMMUNODEFICIENT ANIMALS: MODELS FOR CANCER RESEARCH, 1996, 51 : 145 - 150
12345